DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
-
Published:2024-03
Issue:3
Volume:5
Page:101469
-
ISSN:2666-3791
-
Container-title:Cell Reports Medicine
-
language:en
-
Short-container-title:Cell Reports Medicine
Author:
Kirk Allison M., Crawford Jeremy Chase, Chou Ching-Heng, Guy Cliff, Pandey Kirti, Kozlik Tanya, Shah Ravi K., Chung Shanzou, Nguyen Phuong, Zhang Xiaoyu, Wang Jin, Bell Matthew, Mettelman Robert C., Allen E. Kaitlynn, Pogorelyy Mikhail V., Kim Hyunjin, Minervina Anastasia A., Awad Walid, Bajracharya Resha, White Toni, Long Donald, Gordon Brittney, Morrison Michelle, Glazer Evan S., Murphy Andrew J., Jiang Yixing, Fitzpatrick Elizabeth A., Yarchoan Mark, Sethupathy Praveen, Croft Nathan P., Purcell Anthony W., Federico Sara M., Stewart Elizabeth, Gottschalk Stephen, Zamora Anthony E., DeRenzo Christopher, Strome Scott E., Thomas Paul G.ORCID
Funder
NIAID VRC NHMRC National Cancer Institute Assisi Foundation of Memphis Inc Fibrolamellar Cancer Foundation ALSAC
|
|